BioPharma Resources

Drug Trial Radar · NCT02064894

Oral Analgesic Utilization for CHildhood Musculoskeletal Injuries

A Randomized Controlled Trial of Oral Analgesic Utilization for Pain Management of CHildhood Musculoskeletal Injuries

Last checked: Nov 19, 2026Latest source record: Aug 3, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 501 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

501

Actual

Start

Jul 8, 2013

Primary completion

Jun 22, 2015

Study completion Jun 22, 2015

Sponsor

Lead sponsor
St. Justine's HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 17, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 6 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Pain management for children presenting to the emergency department (ED) with an injured limb is often under-treated, even though it is known that broken arms and legs cause moderate to severe pain. Further, children are less likely to receive appropriate pain medicine than adults with similar injuries. This study aims to improve the pain treatment of children who present to the ED with a suspected fracture, or broken bone or severe sprain. The investigators will compare the use of 3 different possible medication combinations (ibuprofen alone, oral morphine alone, or combined ibuprofen and oral morphine) to determine which combination is the best at treating children's pain. The investigators also plan to verify the safety of using these different drugs to treat children's pain. The investigators strongly believe that children's pain should be optimally treated in the ED. Adequately relieving children's pain is crucial, as inadequate pain treatment can have both short and longterm effects on the child. It also generates unnecessary stress for both the child and their caregivers/parents. Given this knowledge, the investigators feel that their study has the potential to impact care provided in EDs, and improve pain management safely, for children.

Conditions

  • Musculoskeletal Injury

Interventions

  • oral morphine and oral ibuprofenDrug

    The combination of oral morphine and oral ibuprofen is one of the Experimental arm group

  • Oral morphineDrug

    Oral morphine 0.2 mg/kg (syrup) up to a maximum dosage of 15 mg, administered once during the study

  • Oral ibuprofenDrug

    oral ibuprofen combine to a placebo is the active comparator

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pain Intensity - Percentage of Children Who Achieved VAS < 30 mmTime frame: 60 minutes post-analgesia

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Stollery Children's Hospital

    Edmonton, Alberta, Canada

  • Children Hospital of Eastern Ontario

    Ottawa, Ontario, Canada

  • St.Justine's Hospital

    Montreal, Quebec, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.